Laennec AI, a pioneering MedTech company based in Cardiff, has raised pre-seed funding ‘to turn every smartphone into a stethoscope’.
Laennec is developing medical devices powered by artificial intelligence for home use. These empower patients to monitor chronic conditions from home while ensuring they are remotely monitored by clinicians.
The investment was secured from SFC Capital and OVC Ventures alongside grant funding from the Welsh Government, Innovate UK and the National Institute for Health Research (NIHR).
The combined support will accelerate the development of affordable medical devices, bringing healthcare closer to patients and ushering in a new era of self-care.
“We envision a world where advanced medical care begins at home, and with this funding, we’re one step closer to making that a reality for millions,” said Dr Jase John, co-founder and CEO.
“By empowering patients with innovative tools and ensuring they are remotely monitored by clinicians, we’re shaping the future of healthcare to be more accessible, personalised, and efficient. We are grateful to our investors and grant partners for their support in making this vision a reality.”
Chiron Health AI raises funds to target chronic disease management
Dr Arathy Varghese, co-founder and CTO, added: “It’s a step towards a healthcare model where patients are active participants in their care.
“By integrating advanced technology into self-care practices, we’re enabling earlier detection, continuous monitoring, and better disease management.”
Harrison Faull, managing director of OVC Ventures, said: “This highly skilled team and transformative approach to diagnostics stood out to us immediately.
“Their technology has the potential to elevate patient care while significantly reducing the operational costs that challenge the NHS and healthcare systems worldwide.
“We look forward to helping the team scale their operations and drive meaningful improvements for patients globally whilst generating a substantial return for our investors.”